Ann E. Taylor's most recent trade in Terns Pharmaceuticals Inc was a trade of 4,676 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Ann E. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,676 | 4,676 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Ann E. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Ann E. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Ann E. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) |